Mycosis Fungoides and Sezary Syndrome — Trials

Mycosis Fungoides and Sezary Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 32
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02542124	NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)	unknown	Phase 2	10	Neumedicines Inc.INDUSTRY	1	Nov 16, 2018	clinicaltrials
NCT02881749	Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides	unknown	Phase 2	68	Thomas Jefferson UniversityOTHER	0	Aug 30, 2016	clinicaltrials